• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 971

Bacillus clausii strain 088AE spore preparation

Intended Use: Intended for use as an ingredient at a maximum level of 2 x 109 colony forming units (cfu)/serving in baked goods and baking mixes, breakfast cereals, cheeses, alcoholic beverages, nonalcoholic beverages and beverage bases, coffee and tea, milk and milk products, dairy product analogs, fats and oils, fresh fruit juices, condiments and relishes, confections and frostings, frozen dairy desserts and mixes, fruit and water ices, drinking water, sports drinks, gelatins, puddings and fillings, jams and jellies, alcoholic beverages, grain products and pastas, hard candy and cough drops, soft candy, chewing gum, herbs, seeds, spices, seasonings, blends, extracts, and flavorings, nuts and nut products, plant protein products, processed fruits, processed vegetables and vegetable juices, snack foods, soups and soup mixes, sugar and sweet sauces, toppings, and syrups.
Basis: Scientific procedures
Notifier: Advanced Enzyme Technologies Ltd.
Notifier Address: 5th Floor, A wing, Sun Magnetica
L.I.C. Service Road, Louiswadi
Thane (W) 400 064
GRAS Notice (releasable information): GRN 971 with amendments (in PDF) (8.2 MB)
Date of closure: Mar 3, 2022
FDA's Letter: FDA has no questions (in PDF) (150 kB)